Mediracer®

Related Studies

Mediracer® NCS is toolkit for diagnosing and evaluating carpal tunnel syndrome, diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.

Studies

Below you can find multiple CTS, DPN, CIPN and Mediracer NCS related studies.

 

Carpal Tunnel Syndrome:


 

Improving the Diagnosis of Carpal Tunnel Syndrome
Prof Michael Sedgwick, MD FRCP

 

Nerve conduction studies and EMG in carpal tunnel syndrome: Do they add value?

MasahiroSonoo, Daniel L.Menkes, Jeremy D.P.Bland, DavidBurke. Clinical Neurophysiology Practice Volume 3, 2018, Pages 78-88

 

A Handheld Nerve Conduction Measuring Device In Carpal Tunnel Syndrome
U.Tolonen, M.Kallio, J.Ryhänen, T.Raatikainen, V.Honkala, V.Lesonen and The Study Group. Acta Neurol Scand DOI: 10.111/j.1600-0404.2007.00799.x

 

Carpal Tunnel Syndrome Diagnosis: Validation of a Clinic-Based Nerve Conduction Measurement Device
T.Green, M.Kallio, M.Clarke, P.Pathak, V.Lesonen, U.Tolonen. J. Biomedical Science and Engineering, 2011, 4, 280-286

 

Ring Finger Testing in Carpal Tunnel Syndrome: A Comparative Study of Diagnostic Utility.
Uncini A, Lange DJ, Solomon M, Soliven B, Meer J, Lovelace RE. 1989.
Columbia Presbyterian Medical Center, Department of Neurology
Muscle Nerve, 12: 735–741. doi: 10.1002/mus.880120906

 

ELECTRODIAGNOSTIC EVALUATION OF CARPAL TUNNEL SYNDROME 
Robert A. Werner, MD, MS and Michael Andary, MD, MS
Muscle Nerve 44: 597–607, 2011, AANEM MONOGRAPH

 

The Relationship of Pre- and Post-operative Median and Ulnar Nerve Conduction Measures to a Self-administered Questionnaire in Carpal Tunnel Syndrome
T.P.Green, E.U.Tolonen, M.R.A.Clarke, P.Pathak, M.L.Newey, C.J.Kershaw, M.A.Kallio
Neurophysiologie Clinique/Clinical Neurophysiology (2012), doi:10.1016/j.neucli.2012.02.133

 

NCS/EMG examination for common disorders
The British Society for Clinical Neuropsychology.

 

 

Diabetic Peribheral Neuropathy


 

A Clinical Approach to diabetic peribheral neuropathy

 

Utilization of Nerve Conduction Studies for the Diagnosis of Polyneuropathy in Patients with Diabetes: A Retrospective Analysis of a Large Patient Series

 

Signs and Symptoms vs Nerve Conduction Studies to Diagnose Diabetic Sensorimotor Polyneuropathy

 

AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy

 

Can nerve conduction studies detect earlier and predict clinical diabetic neuropathy? – PubMed Central (PMC)

“Recently, the number of diabetic patients has increased very rapidly and is accompanied by an increasing development of diabetic neuropathies (DNs). The incidence and prevalence of DNs associated with duration of diabetes affects up to 50% of diabetic patients after 25 years of disease.”

 

AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy

“AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy Introduction Distal symmetric polyneuropathy (DSP) is one of the most common problems leading to referral”

Evaluation of Peripheral Neuropathy in the Diabetic Foot | 2017-02-23 | AHC Media – Continuing Medical Education Publishing – reliasmedia.com

“Peripheral neuropathy is a commonly encountered disorder in both the primary care and podiatric clinical settings. Peripheral neuropathy affects the nerves, which impairs sensation, movement, gland or organ function, and other aspects of well-being, including mental health.”

Predictors of Nerve Conduction Study Parameters among Type 2 Diabetic Patients: A Cross -Sectional Study Volume 11 – Issue 2 – biomedres.us

“The prevalence of diabetes is rapidly rising all over the globe and India is becoming the world capital for diabetic patients. Persistent hyperglycemia leads to micro vascular complications like diabetic peripheral neuropathy (DPN) which contributes to significant morbidity in the society.”

Point-of-care devices for detecting diabetic polyneuropathy

01 July 2016 – Publisher: NIHR Community Healthcare MIC

 

Electrodiagnostic Services: Pay for Quality – aanem.org

The British Society for Clinical Neuropsychology
NCS/EMG examination for common disorders

Chemotherapy-Induced Peripheral Neuropathy


 

 

Co-Morbidity Consult: Chemotherapy-Induced Peripheral Neuropathy

 

Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel

 

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

Mediracer® NCS

Quality of our solutions

Are proven by ISO 13485 standard (VTT-C-12332-60-18) and CE mark (VTT-C-11550-01-1102-578-16).

Mediracer has entered the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE).

 

Phone

+358 45 899 2626

Email

info (at) mediracer.com

Location

kasarmintie 13 D
Oulu, 90130
Finland

Send your inquiry via the form below or to info@mediracer.com

6 + 15 =